For example, miR-29 targets integrin β1 and α6 and thus inhibits the integrin-mediated oncogenic function in HNSCC [48,49], and it also targets a diverse mRNA coding for ECM genes, including collagens, fibrillin and elastin [50]. This evidence concerns the gene ELN and head and neck squamous cell carcinoma.